← Writing

Parkinson's and the Chemicals of the West

Parkinson'senvironmental toxicologyneuroscience

In 1817, James Parkinson described a disease he called the "shaking palsy," in which affected patients experience tremors, muscle stiffness and rigidity, and impaired balance and cognition. 1817 coincides with the period just after the Industrial Revolution began in Britain; by contrast, the disease was essentially absent from pre-industrial medical records. Today, Parkinson's Disease (PD) is the fastest-growing neurological disorder in the world — cases doubled between 1990 and 2015 and are projected to double again by 2040, a trajectory that outpaces normal aging and demographic change [5, 10]. Why? There is increasing evidence that the chemicals defining industrialized Western life — pesticides such as paraquat and rotenone, industrial solvents like trichloroethylene, and air pollutants from combustion — increase the incidence of PD. They do so by converging on the same target: the dopamine neurons of the substantia nigra.

Brief Introduction to Pathology

PD is pathologically defined by the degeneration of dopaminergic neurons in the nigrostriatal pathway, particularly neurons in the substantia nigra that project to the striatum [19]. The basal ganglia run motor "loops" that fine-tune movement, and dopamine is the key modulator of those loops; when dopaminergic input is lost, the circuit is lesioned, causing bradykinesia, resting tremor, and rigidity. The pathological hallmark is intracytoplasmic inclusions made of alpha-synuclein in fibrillary form — normally soluble, but here misfolded and aggregated — called Lewy pathology [17, 19]. Because of this pathology, non-motor symptoms such as anosmia (alpha-synuclein pathology in the olfactory bulb) and constipation (relating to the enteric nervous system and dorsal motor nucleus) precede the motor features [2, 11].

The key biological question, then, is not simply why neurons die, but why this particular neuronal population is so vulnerable. Dopamine metabolism is inherently pro-oxidant for several reasons. It can spontaneously generate ROS; monoamine oxidase enzymes (MAOs) perform oxidative deamination on dopamine, producing hydrogen peroxide. With aging in particular, MAO-B activity — the isoform more enriched in glia — rises, so a larger share of dopamine breakdown occurs in surrounding glial cells, expanding the oxidative burden. Dopaminergic neurons also contain high levels of iron, which reacts to form the hydroxyl radical, one of the most damaging ROS in biology. Secondarily, dopaminergic neurons have high energetic demands and are especially vulnerable under stress because of dopamine oxidation, relatively low mitochondrial mass, and excitotoxicity; as a result, mitochondrial dysfunction is a common feature across early PD [17, 19]. In many ways, nigral dopamine neurons are a "loaded gun" — environmental toxins can easily amplify pre-existing vulnerabilities linked to oxidation, mitochondria, and alpha-synuclein.

Western Life?

PD shows historical, geographic, and even occupational patterns that have led scientists to look for plausible environmental causes [5, 10]. Research has linked higher Parkinson's prevalence with growing GDP per capita [5, 10]. Rates of PD are rising fastest in rapidly industrializing nations like China and India, as well as in regions with heavy air pollution [5]. Occupational evidence suggests that many environmental toxins — pesticides, solvents, and air pollution — are associated with higher Parkinson's risk [1, 6, 20], with a pooled risk ratio of 1.41 recorded for pesticide exposure [1].

The First Case

In 1982, J. William Langston encountered several young Bay Area residents who were rigid, mute, and displayed the full presentation of parkinsonism [15]. They had injected synthetic heroin contaminated with a byproduct, MPTP — a small, lipophilic molecule that can cross the blood–brain barrier and is converted to MPP⁺ by MAO-B. MPP⁺ is a toxic metabolite and a good substrate for the dopamine uptake site, so it concentrates specifically in dopaminergic neurons [15]. Once inside nigral dopamine neurons, MPP⁺ concentrates in the mitochondria and inhibits complex I of the respiratory chain, reducing ATP production and generating free radicals, which leads to selective degeneration of nigral dopamine neurons through the cascade described above [15, 18]. This case showed that a single small molecule from industrial chemistry could cause PD in humans within days — a process that normally takes more than half a century [15, 18].

Pesticides

The strongest link between any chemical and Parkinson's is through pesticide use [1, 22]. The first, and most extensively examined, is paraquat, which is chemically very similar to MPP⁺ and has consequently been banned in over 30 countries, though it remains legal in the US [5]. Paraquat drives PD through a redox cycle in which NADPH reduces PQ²⁺, which then reduces O₂ to superoxide, a damaging free radical, generating ROS in already-vulnerable dopaminergic neurons. Specific to dopamine chemistry, studies observe that paraquat exposure increases cytosolic and vesicular dopamine, which is normally packaged into synaptic vesicles; since dopamine naturally produces ROS, this accelerates the oxidation cascade dramatically, producing dopamine-quinone, an electrophile that attacks nucleophilic groups on proteins, leading to damage in mitochondrial proteins and aggregation of alpha-synuclein. There is also some, less-explored, evidence that paraquat interferes with protein-clearance biology relevant to Parkinson's — in SH-SY5Y cells, paraquat intensified the interaction between HMGB1 and alpha-synuclein, preventing autophagic clearance and promoting alpha-synuclein accumulation. Studies have shown paraquat exposure associated with Parkinson's disease at an odds ratio of 1.64 (95% CI 1.27–2.13) [21], and the FAME study found an odds ratio of 2.5 (95% CI 1.4–4.7) [22] — though direct causality remains debated.

Rotenone is a lipophilic pesticide that crosses the blood–brain barrier by diffusion and specifically inhibits mitochondrial complex I by binding its ubiquinone site, blocking the first step of the electron transport chain [22]. This causes an ETC failure that reduces ATP production, and causes electrons to accumulate at complex I and leak into molecular oxygen, creating superoxide and other ROS — again a specific vulnerability of nigral dopamine neurons. In rotenone-induced PD mouse models, expression of yeast NDI1, a rotenone-resistant NADH dehydrogenase, improved complex I activity and striatal dopamine content, suggesting mitochondrial complex I failure is mechanistically tied to Parkinson's. In the FAME study, rotenone use was associated with PD at an odds ratio of 2.5 (95% CI 1.3–4.7) [22].

Other pesticides, like dieldrin, are also PD risk factors — studies have detected statistically significant dieldrin presence in postmortem PD brains, and dieldrin-treated alpha-synuclein cells developed protein aggregation and were more sensitive to apoptosis. It is plausible to treat dieldrin as a risk factor rather than a sole cause [8].

Industrial Solvents

A 2023 study of Marine Corps veterans at Camp Lejeune found a 70% higher risk of PD decades later compared to veterans who trained elsewhere. Base water there was heavily contaminated with the industrial solvent TCE, a volatile, lipophilic molecule that can contaminate groundwater, outdoor air, and indoor air [6]. Inhalation exposure can cause rapid diffusion through the brain: one study exposed rats to 50 ppm TCE for 8 weeks and mice to 100 ppm TCE for 12 weeks, and both species developed nigral dopaminergic degeneration and motor impairments [3]. In vitro and in vivo studies indicate TCE-associated Parkinson's is likely also driven by mitochondrial dysfunction — reduced mitochondrial complex I activity, increased oxidative stress markers, and dopaminergic neuron loss in the substantia nigra have all been observed in rats and industrial workers [4, 6, 9, 16]. One proposed mechanism is that TCE forms TaClo, a potent mitochondrial complex I inhibitor acting similarly to MPP⁺ in Langston's case, since TaClo dosing in mice induces dopaminergic neuronal loss similar to MPP⁺ [4].

Air Pollution

There is evidence that long-term PM2.5 exposure contributes to PD indirectly and cumulatively, rather than instantly [14, 20]. PM2.5 exposure can activate microglia and upregulate inflammatory markers (IL-1β, IL-6, TNFα) [20, 23]. Chronic microglial activation and neuroinflammation can amplify neuron injury through positive feedback loops in which dying neurons release more damage signals that re-stimulate microglia [20]. PM2.5 also promotes alpha-synuclein pathology by directly triggering alpha-synuclein fibrillization [12]. PM2.5 particles can pass through the alveolar-capillary membrane into the bloodstream, and cross the blood–brain barrier or enter through nasal mucus [20]. Higher PM2.5 exposure has been associated with PD risk and with phenotypic measures such as akinetic-rigid presentation and dyskinesia [14]. Ozone and PM2.5 were positively associated with PD in North Carolina farmers, but not in Iowa farmers [13].

Relation to the Braak Hypothesis

The Braak hypothesis offers an explanation for why these Western environmental factors could lead to PD. Braak proposed that alpha-synuclein pathology in some PD brains starts peripherally — Lewy pathology beginning outside or low in the brain, especially in the olfactory system or the gut–vagus pathway, and spreading stepwise rostrally toward the substantia nigra [2, 7]. Once the pathology reaches the substantia nigra, dopaminergic neuron loss and clinical PD appear [2, 17], explaining why anosmia and constipation precede motor symptoms by decades, as noted above [7, 11]. The Braak hypothesis predicts that PD can be triggered by something inhaled or ingested — precisely the route of entry for these environmental factors [7]. Air pollution enters through the nasal route; pesticides often enter through the gut via contaminated food and water; and TCE can be inhaled as vapor or ingested from groundwater. This slower-progressing pathology helps explain why exposure to a pesticide in your 30s might cause symptoms of PD in your 70s.

Conclusion

Industrial-era chemicals are a risk factor for rising PD incidence, amplifying the vulnerable nigral dopamine population through oxidative stress and mitochondrial damage [1, 6, 12, 17, 22]. Two stories explain this. The brain-first, direct-neurotoxicity story is acute: toxins reach the substantia nigra, inhibit complex I and/or generate ROS, and kill dopamine neurons directly. The body-first, peripheral story, related to the Braak hypothesis, suggests toxins contact the olfactory system or the gut and cause alpha-synuclein misfolding locally, with pathology ascending over decades. These are not contradictory mechanisms, but two ends of a spectrum determined by the dose and duration of exposure [7, 11]. Chemicals like MPTP or occupational paraquat favor the direct-toxicity pathway, while more ambient, chronic exposures — contaminated groundwater, air pollution particles — likely rely on the peripheral pathway to produce their decade-long latency.

The dopamine neuron is vulnerable in many ways, and environmental toxins are one of several risk factors, alongside genetic susceptibility, that exploit these vulnerabilities and increase the incidence of PD [7, 19]. In part, the "shaking palsy" first described in 1817 is also a disease we created ourselves [5, 7].

References

  1. Ahmed, H., Abushouk, A. I., Gabr, M., Negida, A., & Abdel-Daim, M. M. (2017). Parkinson's disease and pesticides: a meta-analysis of disease connection and genetic alterations. Biomedicine & Pharmacotherapy, 90, 638–649.
  2. Braak, H., Del Tredici, K., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of Aging, 24(2), 197–211.
  3. De Miranda, B. R., Castro, S. L., Rocha, E. M., Bodle, C. R., Johnson, K. E., & Greenamyre, J. T. (2023). Low-dose inhalation exposure to trichloroethylene induces dopaminergic neurodegeneration in rodents. Toxicological Sciences, 195(1), 1–15.
  4. De-Paula, V. J., Bonadia, L. C., Mansano, N. S., Saretta, T. N., & Forlenza, O. V. (2018). Trichloroethylene and Parkinson's disease: risk assessment. Molecular Neurobiology, 55(7), 6201–6214.
  5. Dorsey, E. R., Sherer, T., Okun, M. S., & Bloem, B. R. (2018). The emerging evidence of the Parkinson pandemic. Journal of Parkinson's Disease, 8(s1), S3–S8.
  6. Dorsey, E. R., Zafar, M., Lettenberger, S. E., Pawlik, M. E., Kinel, D., Frissen, M., Schneider, R. B., Kieburtz, K., Tanner, C. M., De Miranda, B. R., Goldman, S. M., & Bloem, B. R. (2023). Trichloroethylene: an invisible cause of Parkinson's disease? Journal of Parkinson's Disease, 13(2), 203–218.
  7. Dorsey, E. R., Bloem, B. R., & Okun, M. S. (2024). The body, the brain, the environment, and Parkinson's disease. Journal of Parkinson's Disease, 14(3), 451–465.
  8. Furlong, M., Tanner, C. M., Goldman, S. M., Bhudhikanok, G. S., Blair, A., Chade, A., Comyns, K., Hoppin, J. A., Kasten, M., Korell, M., Langston, J. W., Marras, C., Meng, C., Richards, M., Ross, G. W., Umbach, D. M., Sandler, D. P., & Kamel, F. (2015). Protective glove use and hygiene habits modify the associations of specific pesticides with Parkinson's disease. Environment International, 75, 144–150.
  9. Gash, D. M., Rutland, K., Hudson, N. L., Sullivan, P. G., Bing, G., Cass, W. A., Pandya, J. D., Liu, M., Choi, D.-Y., Hunter, R. L., Gerhardt, G. A., Smith, C. D., Slevin, J. T., & Prince, T. S. (2008). Trichloroethylene: parkinsonism and complex 1 mitochondrial neurotoxicity. Annals of Neurology, 63(2), 184–192.
  10. GBD 2016 Parkinson's Disease Collaborators. (2018). Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurology, 17(11), 939–953.
  11. Horsager, J., Knudsen, K., & Sømmerlund, M. (2022). Clinical and imaging evidence of brain-first and body-first Parkinson's disease. Neurobiology of Disease, 164, 105626.
  12. Hu, X., Yang, B., Lu, Y., Lin, Y., Lu, Y., Sun, S., Liu, H., Xie, H., Wang, L., Su, Z., & Sun, Y. (2022). Fine particulate matter triggers α-synuclein fibrillization and Parkinson-like neurodegeneration. Movement Disorders, 37(9), 1812–1824.
  13. Kirrane, E. F., Bowman, C., Davis, J. A., Hoppin, J. A., Blair, A., Chen, H., Patel, M. M., Sandler, D. P., Tanner, C. M., Vinikoor-Imler, L., Ward, M. H., Luben, T. J., & Kamel, F. (2015). Associations of ozone and PM2.5 concentrations with Parkinson's disease among participants in the Agricultural Health Study. Journal of Occupational and Environmental Medicine, 57(5), 509–517.
  14. Krzyzanowski, B., Mullan, A. F., Turcano, P., Camerucci, E., Savica, R., & Benarroch, E. E. (2024). Air pollution and Parkinson disease in a population-based study. JAMA Network Open, 7(10), e2439459.
  15. Langston, J. W. (2017). The MPTP story. Journal of Parkinson's Disease, 7(s1), S11–S19.
  16. Liu, M., Choi, D.-Y., Hunter, R. L., Pandya, J. D., Cass, W. A., Sullivan, P. G., Kim, H.-C., Gash, D. M., & Bing, G. (2010). Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats. Journal of Neurochemistry, 112(3), 773–783.
  17. McCann, H., Cartwright, H., & Halliday, G. M. (2016). Neuropathology of α-synuclein propagation and Braak hypothesis. Movement Disorders, 31(2), 152–160.
  18. Mizuno, Y., Sone, N., & Saitoh, T. (2002). Neurotoxicity of MPTP. Neuropathology, 22(3), 149–160.
  19. Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017). Parkinson disease. Nature Reviews Disease Primers, 3, 17013.
  20. Ritz, B., Lee, P.-C., Hansen, J., Lassen, C. F., Ketzel, M., Sørensen, M., & Raaschou-Nielsen, O. (2019). Air pollution and Parkinson's disease — evidence and future directions. Reviews on Environmental Health, 34(4), 407–415.
  21. Tangamornsuksan, W., Lohitnavy, O., Sruamsiri, R., Chaiyakunapruk, N., Scholfield, C. N., Reisfeld, B., & Lohitnavy, M. (2018). Paraquat exposure and Parkinson's disease: a systematic review and meta-analysis. Archives of Environmental & Occupational Health, 74(5), 225–238.
  22. Tanner, C. M., Kamel, F., Ross, G. W., Hoppin, J. A., Goldman, S. M., Korell, M., Marras, C., Bhudhikanok, G. S., Kasten, M., Chade, A. R., Comyns, K., Richards, M. B., Meng, C., Priestley, B., Fernandez, H. H., Cambi, F., Umbach, D. M., Blair, A., Sandler, D. P., & Langston, J. W. (2011). Rotenone, paraquat, and Parkinson's disease. Environmental Health Perspectives, 119(6), 866–872.
  23. Wang, Y., Li, C., Zhang, X., Kang, X., Li, Y., Zhang, W., Chen, Y., Liu, Y., Wang, W., Ge, M., Du, L., & Sun, Y. (2021). Exposure to PM2.5 aggravates Parkinson's disease via inhibition of autophagy and mitophagy pathway. Toxicology, 456, 152770.